BRIEF-Cogent Biosciences Announces Pricing Of Concurrent Public Offerings Of Common Stock And 1.625% Convertible Senior Notes Due 2031
Reuters
Nov 12
BRIEF-Cogent Biosciences Announces Pricing Of Concurrent Public Offerings Of Common Stock And 1.625% Convertible Senior Notes Due 2031
Nov 11 (Reuters) - Cogent Biosciences Inc COGT.O:
COGENT BIOSCIENCES ANNOUNCES PRICING OF CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND 1.625% CONVERTIBLE SENIOR NOTES DUE 2031
COGENT BIOSCIENCES INC - PRICES PUBLIC OFFERING OF 9,677,420 SHARES AT $31.00 EACH
Source text: ID:nGNX4Dwy8Q
Further company coverage: COGT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.